Ceftaroline: a cephalosporin with expanded Gram-positive activity
- PMID: 19207097
- DOI: 10.2217/17460913.4.1.25
Ceftaroline: a cephalosporin with expanded Gram-positive activity
Abstract
Infections caused by resistant Gram-positive pathogens such as methicillin-resistant Staphylococcus aureus (MRSA) are now posing a major health risk for patients in hospital and community settings. There is a need to evaluate new antibiotics that would offer reliable clinical efficacy combined with a favorable safety profile for the treatment of such infections. Ceftaroline is a new member of the cephalosporin class of antibiotics with expanded activity against Gram-positive pathogens such as MRSA, vancomycin-intermediate S. aureus, vancomycin-resistant S. aureus and multidrug-resistant Streptococcus pneumoniae, while retaining good activity against common Gram-negative organisms. Phase II and III studies have shown ceftaroline to be an effective and well-tolerated treatment for complicated skin and skin-structure infections compared with standard therapy. Trials are ongoing in the treatment of community-acquired pneumonia.
Similar articles
-
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.Ann Pharmacother. 2011 Nov;45(11):1384-98. doi: 10.1345/aph.1Q225. Epub 2011 Oct 18. Ann Pharmacother. 2011. PMID: 22009993 Review.
-
Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv9-16. doi: 10.1093/jac/dkq251. J Antimicrob Chemother. 2010. PMID: 21115457 Review.
-
Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Drugs. 2012 Jul 30;72(11):1473-93. doi: 10.2165/11635660-000000000-00000. Drugs. 2012. PMID: 22779432 Review.
-
Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Expert Rev Anti Infect Ther. 2009 Sep;7(7):777-91. doi: 10.1586/eri.09.54. Expert Rev Anti Infect Ther. 2009. PMID: 19735220 Review.
-
Ceftaroline fosamil: drug profile and clinical data.Future Microbiol. 2011 Jan;6(1):9-18. doi: 10.2217/fmb.10.132. Future Microbiol. 2011. PMID: 21162631
Cited by
-
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.Diagn Microbiol Infect Dis. 2015 May;82(1):65-9. doi: 10.1016/j.diagmicrobio.2015.02.003. Epub 2015 Feb 14. Diagn Microbiol Infect Dis. 2015. PMID: 25737290 Free PMC article.
-
Comparative pharmacokinetics of ceftaroline in rats, rabbits, and monkeys following a single intravenous or intramuscular injection.Antimicrob Agents Chemother. 2010 Feb;54(2):912-4. doi: 10.1128/AAC.00645-09. Epub 2009 Nov 30. Antimicrob Agents Chemother. 2010. PMID: 19949051 Free PMC article.
-
Optimized Synthesis of New N-Mustards Based on 2-Mercaptobenzoxazole Derivatives with Antitumor Activity.Biomedicines. 2021 Apr 26;9(5):476. doi: 10.3390/biomedicines9050476. Biomedicines. 2021. PMID: 33926050 Free PMC article.
-
Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA).Clin Med Rev Ther. 2011 Feb 10;3:a2466. doi: 10.4137/CMRT.S1637. Clin Med Rev Ther. 2011. PMID: 21785568 Free PMC article.
-
Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia.Infect Drug Resist. 2012;5:43-51. doi: 10.2147/IDR.S17433. Epub 2012 Feb 1. Infect Drug Resist. 2012. PMID: 22355258 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
